- Prevalence of Autoimmune Diseases in Thymic Epithelial Tumors (TET) Insights from RYTHMIC
- Autoimmune diseases in centrally reviewed Thymic Epithelial Tumors (TET)
- Pathological central review of 290 thymic epithelial tumors (TET) : The national network RYTHMIC experience.
- Sunitinib in patients with advanced thymic malignancies: Cohort from the French RYTHMIC network
- Systemic therapy in advanced thymic epithelial tumors: Insights from the RYTHMIC prospective cohort
- Synopsis: RYTHMIC_résumé_20160527.pdf